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A B S T R A C T
Background and aim: Epicardial approach to VT ablation increases the success rate of ablation but is not
without complications. We studied the safety and efﬁcacy of epicardial VT ablations performed at our
institute.
Methods: All patients who underwent epicardial VT ablation at our institute were studied
retrospectively. The outcome of VT ablation was among three groups: ischaemic cardiomyopathy
(ICM), non-ischaemic cardiomyopathy (NICM) and granulomatous myocarditis (GM). Safety outcomes
assessed included all complications considered to be due to pericardial access or epicardial mapping/
ablation.
Results: A total of 54 patients (total 119 VTs, mean 2.2 (0.9)) were taken up for ablation procedure
through epicardial access. Mean age: 47 (10) years, males: 83%. All patients had drug resistant recurrent
VTs. The epicardial procedure was abandoned in three patients due to access issues; percutaneous sub-
xiphoid access was employed in 48 and surgical approach in four patients. Complete success was
achieved in 59% and partial success in 76%. The outcomes were poor in ICM patients as compared to those
with GM and NICM. Overall success rates for all clinical VTs were 89% in GM, 90% in NICM and 67% in ICM.
Success rates for epicardial VT ablation were 94%, 85% and 78% respectively for GM, NICM and ICM.
Procedure related complications occurred in six patients.
Conclusion: Epicardial ablation for VT offers good immediate outcomes with acceptable safety proﬁle.
 2016 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Contents lists available at ScienceDirect
Indian Heart Journal
jo u rn al h om epag e: ww w.els evier .c o m/lo cat e/ ih j1. Introduction
Ablation of ventricular tachycardia (VT) is associated with
variable success rates. Despite advancements in technology and
improved understanding of arrhythmia mechanisms, acute and
long-term success rates of endocardial ablation remains modest.1–
3 An important reason cited for the failure is the presence of the re-
entry circuits deep within the endocardium or on the epicardium.
Epicardial location of VT is observed in about 70% of patients
with Chaga’s disease.4 Presence of epicardial substrates, its density
and distribution is increasingly being recognized in other forms of
scar-related cardiomyopathies4–13 too. In patients undergoing
endocardial ablation of VT, about 15–30% of failures are being
attributed to the epicardial location of re-entry circuits.14 Failure* Corresponding author at: Arrhythmia and Electrophysiology Services, CARE
Hospital, Road No.1, Banjara Hills, Hyderabad 500 034, India.
E-mail address: Calambur@hotmail.com (C. Narasimhan).
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0019-4832/ 2016 Published by Elsevier B.V. on behalf of Cardiological Society of
creativecommons.org/licenses/by-nc-nd/4.0/).rates vary with different etiologies ranging from 50 to
80%.6,11,12,15–17 With high prevalence of epicardial location of
re-entry circuits and high rate of recurrence of VT after endocardial
ablations, the epicardial approach in tackling these conditions is
increasingly being recognized.
Epicardial approach to VT ablation is being performed routinely
in some institutions with variations in patient selection, approach
and strategies related to mapping and ablation.5,7,8,10,18,19 We
studied the acute safety and efﬁcacy of epicardial VT ablations
done at our Institute.
2. Materials and methods
This is a retrospective study of all patients who underwent
epicardial access for ablation of VT at our Institution from August
2008 till November 2015. It includes both ﬁrst line (direct
epicardial) and second-line approach. In the second line approach,
mapping was performed initially using the endocardial approach.
Based on the mapping information we decided to access thecacy of epicardial approach to catheter ablation of ventricular
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recording during an episode of VT revealed features of epicardial
origin or scar conﬁned to the epicardium was observed on cardiac
magnetic resonance (CMR) imaging. Procedure was performed
after obtaining informed consent from all patients. Beta-blockers
were stopped ﬁve half-lives and amiodarone three weeks before an
elective procedure. Mexiletine was stopped three days prior to the
procedure.
All procedures were performed under local anaesthesia and
conscious sedation.20 General anaesthesia was mainly reserved for
patients who underwent surgical access to the pericardium.
Sedation was initiated with intravenous bolus of midazolam
hydrochloride (1 mg). The doses were repeated depending on the
level of consciousness of the patients. In addition, intravenous
fentanyl citrate 20 mcg was used followed by 2–3 mcg/min of
infusion for short-term analgesia.
2.1. Mapping, induction and ablation procedure
All procedures were done under intravenous anticoagulation
using intravenous heparin with initial bolus of 50–100 IU/kg
followed by a 1000 IU/h perfusion. The maintenance dose was
titrated to maintain the activated clotting time above 250/300 s.
Vascular access was obtained via right femoral vein and artery.
Quadripolar catheters were positioned in the region of His bundle,
right ventricle and right atrium through femoral venous access.
Mapping and ablation was performed with 3.5 mm open irrigated
tip ThermoCool, Navistar, catheter (Biosense Webster, Diamond
Bar, California). Three dimensional electroanatomic mapping was
done with CARTO (Biosense Webster, Diamond Bar, CA) or NavX
system (St Jude Medical, Minneapolis, MN).
Ventricular tachycardia induction was performed with
programmed electrical stimulation (PES) with up to two basic
drive cycle length (CL) of 600 and 400 milliseconds (ms) and 1–3
extra stimuli from right ventricular apex and outﬂow tract. If VT
was not induced at baseline, isoprenaline was infused for
facilitation.
Unstable VTs were mapped during sinus rhythm and
substrate mapping. Channels and entry and exit sites were
further deﬁned by pace mapping. Bipolar pace-mapping was
performed at 10 mA and a pulse width 2 ms. During activation
mapping, mid-diastolic or pre-systolic potentials were sought,
entrainment was performed and critical isthmus of the VT re-
entrant circuit deﬁned. Radiofrequency (RF) energy was deliv-
ered at sites where there was concealed entrainment with
stimulus to QRS (S-QRS) nearly equal to electrogram to QRS
duration and post pacing interval nearly identical to tachycardia
cycle length (TCL). If the tachycardia could not be entrained, the
earliest local ventricular electrograms were targeted. During
substrate mapping, areas of low voltage, isolated late potentials
and fractionated potentials were tagged. Following this, stimuli
were given to the tagged area and S-QRS duration was measured
to identify the critical isthmus.
During the procedure, where suggestion of epicardial sub-
strates surfaced, anticoagulation was reversed with intravenous
protamine sulphate and epicardial access was attempted.
2.2. Pericardial access
Percutaneous epicardial access was obtained through the sub-
xiphoid approach using an epidural needle as described previously.
In patients where the percutaneous access failed, the surgical
approach to create a sub-xiphoid window or limited lateral
thoracotomy under general anaesthesia was performed the
following day. The site of surgical access was chosen according
to the area of interest in the epicardium.Please cite this article in press as: Pandian J, et al. Safety and efﬁ
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A coronary angiogram was performed after mapping if ablation
was planned on the left ventricular epicardial wall to ensure the
absence of coronary artery at the site of target. Ablation was
avoided at sites close to a major coronary artery. Injury to the left
phrenic nerve was avoided using the technique as described by Fan
et al.21 In short, a high output pacing (>10 mA) along the left lateral
wall was given to assess phrenic nerve capture during energy
delivery. In case of phrenic nerve capture, manoeuvres to separate
the epicardium from the parietal pericardium were attempted. The
ablation of the target site was avoided if the manoeuvres failed.
After performing ablations for targeted VTs, programmed
stimulation was repeated as pre-ablation. Re-ablations were
attempted for any inducible VTs. In case of repeated inducibility,
the procedure was terminated after 2–3 attempts of ablation. Post
procedure, beta blockers were continued for life and amiodarone
was given on low dose following which it was tapered and stopped
if there was no VT recurrence.
2.4. Acute procedural outcomes: deﬁnition of terms
Complete success: The total elimination of all inducible VT at the
end of the procedure.
Partial success: The elimination of all inducible clinical VTs but
the persistence of non-clinical VT (s).
Failure: The inability to render clinical VT non inducible at the
end of the procedure.
2.5. Procedural complications
Any complication that happened during hospital stay and
deemed to be due to pericardial access or ablation procedure were
considered procedural complications.
2.6. Post-procedural patient care
Following the procedure, excess ﬂuid within the pericardium
was drained and a pig tail catheter was left within the pericardium
after administering intra-pericardial methylprednisolone. A trans-
thoracic echocardiogram was performed three hours and 24 h
following the procedure. The pericardial drain was removed after
24 h if the collection was 50 ml. The clinical course of all patients
until discharge was traced and recorded.
2.7. Statistical analysis
Continuous variables are represented as mean and standard
deviation where data follows normal distribution, otherwise as
median with range. Data was analyzed using STATA 13.
3. Results
Between August 2008 till December 2015, a total of 54 patients
(total 119 VTs, mean 2.2 (0.9)) were taken up for ablation
procedure through epicardial access. The mean age was 47 (10)
years with 45 (83%) males. Table 1 gives baseline demographics
and clinical proﬁle of all patients.
3.1. Indications for radiofrequency ablation
Twenty-eight patients (52%) had implantable cardioverter
deﬁbrillator (ICD). Recurrent, appropriate shocks were the indica-
tion of RFA in all these patients. Eighteen patients had either VT
storm or incessant VT and the remaining eight patients had
recurrent haemodynamically unstable VT.cacy of epicardial approach to catheter ablation of ventricular
p://dx.doi.org/10.1016/j.ihj.2016.10.010
Table 1
Baseline demographics and clinical proﬁle of patients.
Variables Number (%) or mean (SD)
Hypertension 23 (43%)
Diabetes mellitus 15 (28%)
Previous cardiac surgery 3a
Mean LVEF 40% (10)
Severe LV dysfunctionb 6 (11%)
Renal dysfunctionc 5 (9%)
Underlying aetiology
Granulomatous myocarditisd 19 (35%)
Ischaemic cardiomyopathy 17 (32%)
Non-ischaemic cardiomyopathy + otherse 18 (33%)
a Coronary artery bypass grafting in two patients and valvular surgery in one
patient.
b Left ventricular ejection fraction 30%.
c Includes patients with Serum. Creatinine 1.5 mg/dl.
d Includes patients with sarcoidosis, tuberculosis and tubercular sarcoidosis.
e Others include Arrhythmogenic right ventricular cardiomyopathy (2 patients)
and hypertrophic cardiomyopathy (2 patients).
LVEF, left ventricular ejection fraction.
Table 2
Characteristics of the induced ventricular tachycardias.
Variables Number (%) or
mean (SD)
QRS axis Right axis deviation 65 (55%)
Left axis deviation 29 (24%)
Extreme right axis 25 (21%)
VT morphology Right bundle block morphology 76 (64%)
Left bundle block morphology 43 (36%)
Total no. of VTs 119
Clinical VTs Clinical VT 84 (71%)
Epicardial VT Epicardial VT 79 (66%)
VT, ventricular tachycardia.
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Pericardial access: Pericardial access was achieved in 48 patients
through percutaneous approach and in four patients through
surgical approach. Pericardial access was abandoned in two
patients due to signiﬁcant bleeding during sub-xiphoid puncture
(Fig. 1).
Access to epicardium: Pericardial adhesions precluded access to
the epicardial targets in three patients who had undergone
previous cardiac surgery. In two patients, we were successfully
able to access the epicardium by performing manual separation of
the adhesions with the mapping catheter. In one patient, the
catheter based separation of adhesions was unsuccessful. Surgical
access was considered high risk in this patient as it requiredFig. 1. Flow diagram of patients undergoing pericardial and epicardial access. Legend: * Pe
epicardial access.
Please cite this article in press as: Pandian J, et al. Safety and efﬁ
tachycardia – An institutional experience, Indian Heart J. (2016), httsternotomy and cardiopulmonary bypass. Hence, the procedure
was abandoned.
The results given below are of 51 patients, excluding the four in
which epicardial procedure was abandoned.
3.3. Mapping
We performed substrate mapping in 15 patients (29%), pace
mapping in 12 patients and activation mapping in one. In the
remaining 23 patients, a combination of strategies was used. All
procedures were performed under three-dimensional electroana-
tomic guidance mapping (CARTO in 49 and NavX in 1). The
characteristics of the induced VTs are given in Table 2.
3.4. Ablation and outcomes
Overall, in 51 patients, 113 VTs were induced of which 74% were
ablated successfully. Eighty of 113 VTs (71%) were clinical VTs.
Ventricular tachycardias from epicardial substrate constituted 65%
of the total VTs. Complete success was achieved in 30 patientsricardial access abandoned due to severe bleeding; y Extensive adhesions precluded
cacy of epicardial approach to catheter ablation of ventricular
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Fig. 2. Proportion of VTs ablated in all patients and in different categorized etiologies compared to the number of VTs induced. Legend: Y Axis in panel A shows the proportion
of clinical and non-clinical VTs ablated to the total no. of VTs induced and panel B shows the proportion of epicardial VTs and endocardial VTs ablated to the total no. of VTs
induced. GM, granulomatous myocarditis; NICM, non-ischaemic cardiomyopathy; ICM, ischaemic cardiomyopathy; Epi, epicardial; Endo, endocardial.
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the VTs from epicardial substrates were ablated. Reasons for failure
to ablated VTs from epicardial substrate include: repeated
inducibility (4 VTs), phrenic nerve capture (3 VTs), adhesions at
target site (2 VTs), and target site proximal to coronary artery
(1 VT). There was no recurrence of VT in any patient until discharge
from hospital. Fig. 2 shows clinical VTs and epicardial VTs ablated
in proportion to the number of VT induced.
3.5. Support and special manoeuvers
Seven patients required endotracheal intubation and mechani-
cal ventilation in which ﬁve were elective: for surgical epicardial
access in four patients and for creating deliberate transient apnoea
in one patient who had phrenic nerve capture. Mechanical
ventilation was required in one patient for completion of the
procedure in whom haemodynamically unstable VT was induced.
For the epicardial targets, in one of the patients who had a
surgical approach, we did a cryoablation as this patient had to be
ablated in close proximity to the crux region.
Phrenic nerve capture was observed in ﬁve patients. As
mentioned above, we used mechanical ventilation to induce
transient apnoea for ablation in one. By preventing respiratory
movements, apnoea transiently displaces the phrenic nerve from
the epicardium during which time the ablation was performed. In
another patient, we introduced the Tyshak balloon catheter and
positioned it in the epicardial site requiring ablation. The balloon
was then inﬂated to create a space between the epicardium and the
phrenic nerve during ablation. Ablation of the VT was avoided in
three patients as the damage to phrenic nerve seemed inevitable.
3.6. Complications
Complications occurred in seven (12.9%) out of 54 patients. Six
patients had pericardial effusion leading to tamponade in three.
The tamponade was managed effectively in all three patients by
use of pig tail catheter. There was one death in the post procedural
period. This elderly patient had pre-existing renal dysfunction and
had a prolonged procedure under general anaesthesia. PostPlease cite this article in press as: Pandian J, et al. Safety and efﬁ
tachycardia – An institutional experience, Indian Heart J. (2016), httprocedure, he developed hyperkalemia due to worsening renal
dysfunction and died due to electromechanical dissociation.
4. Discussion
The results from our centre build on to the evidence on the
favourable safety and efﬁcacy proﬁle of the epicardial ablation of
VT. Successful ablation was possible in the majority of patients. The
procedure served as a bail out for most patients as they presented
with drug resistant VT.
The success of the epicardial ablation procedure depends on
many factors such as feasibility of approach, complications and the
underlying aetiology.
4.1. Feasibility
The feasibility of the procedure depends both on accessibility to
the pericardial space and access to the ablation site. Access to the
pericardial site by the percutaneous approach may be limited due
to adhesions as seen in few of our patients. In such cases, the
pericardial space could be approached with dissecting manoeuvers
using an ablation catheter. Surgical approach also helps access to
the pericardial space.
Critical structures like the presence of coronary artery or the
phrenic nerve at the target site may also prevent ablation. While it
is best to avoid ablations at targets near epicardial arteries, there
are different manoeuvres described by various operators in dealing
with substrates close to phrenic nerve. The techniques aim to
creating a space between the epicardium and parietal pericardium
to allow for ablations without injuring the phrenic nerve. We used
deliberate transient apnoeic period by mechanical ventilation in
one patient and Tyshak balloon inﬂation in one patient to avoid
phrenic nerve injury. When injury to phrenic nerve appears
inevitable, it is better to avoid ablation at the particular site. The
decision to manoeuver needs to be decided on case to case basis.
The presence of epicardial fat over the target site may also interfere
and reduce the effectiveness of ablation. However, we did not
experience this limitation in our group of patients.cacy of epicardial approach to catheter ablation of ventricular
p://dx.doi.org/10.1016/j.ihj.2016.10.010
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Acute, major complications include bleeding from epicardium
due to damage caused during sub-xiphoidal puncture or epicardial
ablation. The initial reported incidence of this complication was
very high. Recent reports from experienced centres show a
signiﬁcant decline in this complication (3.5–9%).10,18,19,22 In our
series, six of the seven complications that occurred were due to
pericardial bleeding. In case of post procedural pericardial
bleeding, tamponade can be avoided by leaving the pig tail
catheter in situ as is done as a protocol in our centre. Owing to the
risk of serious complications associated with the procedure, the
current consensus guidelines4 advocate epicardial approach only
after a failed endocardial ablation. However, institutional pre-
ferences vary in the approaches. We preferred the second line
approach as endocardial VTs are present in many of patients
concomitantly. When the need for an epicardial approach was felt
during endocardial mapping, reversal of anticoagulation by
intravenous protamine sulphate helped in epicardial puncture
without any major bleeding complications in all but two patients
in whom we abandoned epicardial access.
Damage to coronary artery, diaphragm or abdominal organs,
severe pericarditis apart from injury to phrenic nerve are some
of the other complications that have been reported.23,24 Though
serious complications are a concern with epicardial ablation,
proper precautions could help prevent them in majority of the
cases. Coronary angiogram before ablation helps in avoiding
injury to major coronary arteries as seen in a patient in our
group.
4.3. Efﬁcacy
Acute procedural success was comparable to the results from
other centres. In our series of patients, we were able to ablate 74%
of the VTs with complete success achievable in 59% of the patients.
Complete elimination of all inducible VTs is difﬁcult to achieve.
Attempts should be made to ablate all inducible clinical VTs to
provide symptomatic relief to the patients. We were successful in
eliminating 76% of clinical VTs. As the indications for ablation in
our patients were incessant VT/recurrent VT or VT storm in the
majority, even partial success with the elimination of dominant
clinical VTs resulted in substantial palliation of the VT burden in
majority of our patients.
When analyzed according to the type of underlying aetiology,
the procedure was most successful in patients with VT due to GM
followed by those with NICM + (81% and 72% respectively)
compared to 66% in patients with ICM. The reasons for the
differential outcomes is however not easily discernable. We
assigned a separate category for patients with granulomoutous
myocarditis as they were in comparable numbers to the other
groups. Septal intramural circuits/extensive right ventricular
(RV) scars were the reason for failure to abolish all VTs in this
group. Each aetiology may have different target locations,
substrate morphologies with variability in behaviour. We feel
that mapping and ablation strategies should be highly individu-
alized based on the underlying substrate and the clinical
condition of the patient.
4.4. Limitations
The major limitation of the study is that we assessed only the
acute outcomes. Therefore, the efﬁcacy of the procedure in
preventing VT recurrences in long term is not known. Being a
single-centre study and majority of the procedures largely
performed by a single-operator prevents the generalizability of
the study results.Please cite this article in press as: Pandian J, et al. Safety and efﬁ
tachycardia – An institutional experience, Indian Heart J. (2016), htt5. Conclusion
Catheter ablation of VT can be performed safely via percutane-
ous epicardial approach for patients with epicardial circuits with
good immediate outcome. The outcomes are better in patients
with granulomatous myocarditis, which accounted for a third of
our patient population. Proximity to a major coronary artery,
pericardial adhesions and phrenic nerve stimulation precludes
routine use of this approach.
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